R. Michael Carruthers

2013 - Array BioPharma

In 2013, R. Michael Carruthers earned a total compensation of $858.8K as Former Chief Financial Officer at Array BioPharma, a 32% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,310
Option Awards$331,556
Salary$348,900
Other$29,992
Total$858,758

Carruthers received $348.9K in salary, accounting for 41% of the total pay in 2013.

Carruthers also received $148.3K in non-equity incentive plan, $331.6K in option awards and $30K in other compensation.

Rankings

In 2013, R. Michael Carruthers' compensation ranked 7,301st out of 12,286 executives tracked by ExecPay. In other words, Carruthers earned more than 40.6% of executives.

ClassificationRankingPercentile
All
7,301
out of 12,286
41st
Division
Manufacturing
2,614
out of 4,612
43rd
Major group
Chemicals And Allied Products
811
out of 1,462
45th
Industry group
Drugs
608
out of 1,156
47th
Industry
Pharmaceutical Preparations
481
out of 890
46th
Source: SEC filing on September 18, 2015.

Carruthers' colleagues

We found seven more compensation records of executives who worked with R. Michael Carruthers at Array BioPharma in 2013.

2013

Ron Squarer

Array BioPharma

Chief Executive Officer

2013

Ron Chief

Array BioPharma

Executive Officer

2013

Andrew Robbins

Array BioPharma

Chief Operating Officer

2013

Michael Needle

Array BioPharma

Chief Medical Officer

2013

Kevin Koch

Array BioPharma

Chief Scientific Officer

2013

David Snitman

Array BioPharma

Chief Operating Officer

2013

John Moore

Array BioPharma

General Counsel

You may also like